0.80%| Prev Close: | 0.22 |
|---|---|
| Open: | 0.24 |
| Bid: | 0.22 x 200 |
| Ask: | 0.28 x 200 |
| 1y Target Est: | 4.00 |
| Beta: | 1.65 |
| Next Earnings Date: | N/A |
| Day's Range: | 0.22 - 0.25 |
|---|---|
| 52wk Range: | 0.18 - 0.50 |
| Volume: | 52,950 |
| Avg Vol (3m): | 11,008 |
| Market Cap: | 11.21M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.40 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal YearPR Newswire(Wed, May 15)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Changes in Registrant's Certifying AccountantEDGAR Online(Thu, May 2)
- AOXING PHARMACEUTICAL COMPANY, INC. FinancialsEDGAR Online Financials(Thu, Feb 21)
- Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal YearPR Newswire(Fri, Feb 15)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Feb 14)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly ReportEDGAR Online(Fri, Nov 30)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Nov 14)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Oct 15)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, Oct 10)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly ReportEDGAR Online(Mon, Oct 1)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q/A, Quarterly ReportEDGAR Online(Fri, Sep 28)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim ReviewEDGAR Online(Thu, Aug 16)
- Aoxing Pharmaceutical announces resignation of CFO Bob Yunjuntheflyonthewall.com(Fri, Jul 6)
- AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Thu, Jul 5)
Press Releases
Reports
- AOXING PHARMACEUTICAL CO (AXN) 12-months forecastPechala's Reports(May 18)
- Aoxing Pharmaceutical Company Inc: Business description, financial summary,...Reuters Investment Profile(May 18)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 17)